Biological Information
Background Information:
Muscarinic receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Muscarinic receptors are widely distributed in the central and peripheral nervous system as well as various tissues.
Family:
GPCR
Sub Family:
Acetylcholine (Muscarinic)
Class:
Class A
Protein Name:
M3
Uniprot Number:
P20309
Protein Aliases:
acetylcholine receptor, muscarinic 3
Gene Name:
CHRM3
Gene ID:
1131
Accession Number:
NM_000740
Organism:
Human
Construct Details:
Full Length, Recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Binding
Detection Method:
Radiometry
Measured Response:
Scintillation
Testing Information
Procedure Summary:
Human recombinant muscarinic M3 receptors expressed in CHO-K1 cells are used in modified Tris-HCl buffer pH 7.4. A 12 µg‡ aliquot is incubated with 0.8 nM [³H]N-Methylscopolamine for 120 minutes at 25℃. Non-specific binding is estimated in the presence of 1 µM atropine. Receptors are filtered and washed, the filters are then counted to determine [³H]N-Methylscopolamine specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.
Ligand:
[³H] N-Methylscopolamine
Ligand Kd (nM):
0.75
Ligand Concentration:
0.8 nM
Non Specific:
1 µM Atropine
Incubation:
120 min at 25°C
Control Inhibitor:
4-Damp methiodide
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
10 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
CNS/Addiction/Pain
Adverse / Beneficial Action:
A muscarinic M3 subtype receptor antgonist may reduce bronchial tone in chronic obstructive pulmonary disease (COPD) and asthma, gastrointestinal motility as well as interfere with ocular accommodation and outflow facility.
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS